Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine

ClinicalTrials.gov ID: NCT05516992

Public ClinicalTrials.gov record NCT05516992. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety and Efficacy of SB-01 For Injection for the Treatment of Lumbar Degenerative Disc Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and related disability due to Lumbar Degenerative Disc Disease. The primary effectiveness hypothesis is superiority of the investigational product relative to control in terms of the percentage of subjects improving in pain-related disability.

Study identification

NCT ID
NCT05516992
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Spine BioPharma, Inc
Industry
Enrollment
417 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 19, 2022 (Actual)
Primary completion
Mar 21, 2025 (Actual)
Completion
Aug 27, 2025 (Estimated)
Last update posted
Jun 10, 2025

2022 – 2025

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35209 —
Evolve Clinical Research Phoenix Arizona 85013 —
Neurovations Research Napa California 94558 —
Source Healthcare Santa Monica California 90403 —
Science Connections, LLC Doral Florida 33178 —
Coastal Clinical Research Jacksonville Florida 32205 —
Conquest Research Orlando Florida 32804 —
Conquest Research Orlando Florida 32832 —
Pain Relief Centers St. Petersburg Florida 33709 —
Tampa Pain Relief Center Tampa Florida 33603 —
Florida Pain Relief Group Tampa Florida 33614 —
Conquest Research Winter Park Florida 32789 —
Vista Clinical Research, LLC Newnan Georgia 30265 —
Injury Care Research Boise Idaho 83713 —
The Orthopaedic Research Foundation, Inc (OrthoIndy) Indianapolis Indiana 46278 —
Abay Neuroscience Center Wichita Kansas 67226 —
OrthoNebraska Omaha Nebraska 68144 —
Pioneer Clinical Research New York New York 10016 —
Meta Medical Research Institute Cincinnati Ohio 45069 —
META Medical Research Institute Dayton Ohio 45432 —
The Orthopedic Center Tulsa Oklahoma 74104 —
HD Research Bellaire Texas 77401 —
NeuroCare Partners Houston Texas 77008 —
South Texas Spinal Clinic San Antonio Texas 78240 —
Precision Spine Care Tyler Texas 75701 —
Tranquil Clinical Research Webster Texas 77598 —
Wasatch Clinical Research Salt Lake City Utah 84107 —
University of Utah Salt Lake City Utah 84108 —
Virginia iSpine Physicians Richmond Virginia 23235 —
Gershon Pain Specialists Virginia Beach Virginia 23454 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05516992, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05516992 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →